Beaufour IPSEN China

Last updated: 13.02.2014

Address: 18 Kaihua Road,
Tianjin Huayan Hi Tech Industry ParkFukang Road,
Nankai district, Tianjin 300384,China

Tel: +86 22 83 71 03 43


Company description

Beaufour IPSEN entered China in 1992. In 1997, the group invested 200 million RMB to build Beaufour IPSEN (Tianjin) Pharmaceutical Co., Ltd., a Sino-French joint venture in Tianjin Huayuan Hi-Tech Industry Park where it occupies a surface area of 25 000 m2.

Beaufour IPSEN (Tianjin) Pharmaceutical Co., Ltd. now has almost 300 employees and there are 19 offices in China. In April 2000, Beaufour IPSEN (Tianjin) Pharmaceutical Co., Ltd. started the local production of smecta® – a mucous protective agent of digestive tract.

China is one of the most important markets for the development of Beaufour IPSEN group and Beaufour IPSEN is preparing to expend its dimension in China and it is expected to launch 2 or 3 products every year. The target of Beaufour IPSEN (Tianjin) Pharmaceutical Co., Ltd. is to be the leader in every one of its segments and to be one of the top 30 pharmaceutical enterprises of China.

Products and services

Endocrinology, Oncology, Haemotology, Neurology



We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here